Research study Program year 2020 Source: CMS Open Payments

AMG 145 - A single dose relative bioavailability study

Research payments

$159,643

1 payment

Through program year 2020, $159,643 in research payments was reported against AMG 145 - A single dose relative bioavailability study, across 1 payment, paid by Amgen Inc..

Paid by: Amgen Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

1 row

Year	Kind	Amount	Payments
2020	Research	$159,643	1

Breakdown

Who paid Research payments · program year 2020

Amgen Inc. $159,643 1 payment

Who received the money Research payments · program year 2020

Wcct Global INC Organisation paid for research $159,643 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

1 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

Robina Smith Fullerton, CA Named on 1 payment

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.